Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OptimizeRx (OPRX) Profit After Tax (2016 - 2025)

Historic Profit After Tax for OptimizeRx (OPRX) over the last 17 years, with Q3 2025 value amounting to $779000.0.

  • OptimizeRx's Profit After Tax rose 10853.79% to $779000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $34000.0, marking a year-over-year increase of 10014.07%. This contributed to the annual value of -$20.1 million for FY2024, which is 1448.25% down from last year.
  • OptimizeRx's Profit After Tax amounted to $779000.0 in Q3 2025, which was up 10853.79% from $1.5 million recorded in Q2 2025.
  • OptimizeRx's 5-year Profit After Tax high stood at $1.5 million for Q2 2025, and its period low was -$9.1 million during Q3 2024.
  • Moreover, its 5-year median value for Profit After Tax was -$2.9 million (2023), whereas its average is -$2.6 million.
  • As far as peak fluctuations go, OptimizeRx's Profit After Tax tumbled by 879000.85% in 2022, and later skyrocketed by 13822.36% in 2025.
  • Quarter analysis of 5 years shows OptimizeRx's Profit After Tax stood at $623462.0 in 2021, then plummeted by 152.26% to -$325836.0 in 2022, then plummeted by 1171.19% to -$4.1 million in 2023, then surged by 98.12% to -$78000.0 in 2024, then soared by 1098.72% to $779000.0 in 2025.
  • Its Profit After Tax stands at $779000.0 for Q3 2025, versus $1.5 million for Q2 2025 and -$2.2 million for Q1 2025.